FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15063811000001100: Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
53251801000001115 Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
53251901000001114 Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Is a Product containing precisely cabergoline 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) 20 tablet Has AMP True Cabergoline 2mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start